Endovascular treatment of the subclavian artery: stent implantation with or without predilatation.
The endovascular treatment of subclavian artery (SA) lesions is less invasive than open surgical repair, with a low rate of complications. We report our experience in 89 subclavian obstructive lesions (n = 86) treated with stenting: 76 (85.3%) stenoses and 13 (14.6%) total occlusions. The left side was most frequently involved (83.1%), localized at the prevertebral segment in 91%. Technical success was obtained in 83 (93.3%) cases, 100% in stenotic lesions and 53.8% in total occlusions. There were nine global complications (10.1%): five (5.6%) at site of puncture, two distal embolization (2.2%), and two (2.3%) major events. The long-term follow-up was 3.51 +/- 1.98 years, during which time 13 (16.8%) restenoses and 2 (2.6%) reocclusions were noted. Subgroup analysis of patients with stenting after predilatation versus direct stenting technique showed in-hospital complications only in the first group, with a restenosis rate of 28.5% vs. 4.7%, respectively (P = 0.003). We consider stenting for SA obstructive lesions the first therapeutic option.
Amor
Max
M
Section of Interventional Cardiology, Polyclinique Louis Pasteur, Essey-les-Nancy, France.
Eid-Lidt
Guering
G
Chati
Zukai
Z
Wilentz
James R
JR
D000368:Aged; D000800:Angioplasty, Balloon; D001916:Brachial Artery; D003251:Constriction, Pathologic; D005260:Female; D005263:Femoral Artery; D006801:Humans; D008297:Male; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D012189:Retrospective Studies; D015607:Stents; D013348:Subclavian Artery